Sino Biological introduces a new standard for endotoxin levels in biological products.
- Sino Biological's ProPure sets a new standard for endotoxin levels
- Breakthrough product achieves 0.05 EU/mg
- Enhances reliability in biological applications
Sino Biological has unveiled its latest product, ProPure, which establishes a new ultra-low endotoxin standard in biological research. This breakthrough allows for endotoxin levels as low as 0.05 EU/mg, significantly improving the quality of biological products. The achievement is hailed as a critical advancement that will enhance the reliability of results in various applications.
With ProPure, researchers can expect more accurate and dependable outcomes in their studies, as it addresses longstanding issues related to endotoxin contamination. This product's reduced endotoxin levels will prove vital in fields such as vaccine development and cellular therapies. By setting this new benchmark, Sino Biological aims to support scientists and researchers in achieving better experimental conditions.
ProPure is part of Sino Biological's ongoing commitment to innovation in the biomedical field. The company continues to focus on enhancing the quality of biological reagents, emphasizing the importance of lower endotoxin levels for optimal research results. This advancement not only aids in immediate applications but also establishes a new norm in the industry.
